Biogen Inc. buy Royal Bank of Canada
Start price
09.02.26
/
50%
€167.00
Target price
09.02.27
€197.12
Performance (%)
-4.61%
Price
18:03
€159.30
Summary
This prediction is currently active. With a performance of -4.61%, the BUY prediction for Biogen Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 09.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -1.973% | -1.973% |
| iShares Core DAX® | -0.681% | -4.853% |
| iShares Nasdaq 100 | -0.033% | 2.862% |
| iShares Nikkei 225® | -0.536% | -5.024% |
| iShares S&P 500 | -0.211% | 0.925% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target raised by analysts at Royal Bank Of Canada from $217.00 to $233.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat